Back to User profile » Dr Dylan Steen
Paper published by Dr Dylan Steen:
Review
![Noteworthy Comment: The biology and current status of CETP inhibition as a therapeutic target are authoritatively presented in this re-evaluation. Anacetrapib, a potent CETP inhibitor, may prove to be a valuable addition to the clinician's armamentarium.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anacetrapib: potential for the prevention and treatment of coronary heart disease
Steen DL, Khera AV, Cannon CP
Research Reports in Clinical Cardiology 2013, 4:39-53
Published Date: 4 April 2013